Literature DB >> 16442207

2004 WHO classification of the renal tumors of the adults.

Antonio Lopez-Beltran1, Marina Scarpelli, Rodolfo Montironi, Ziya Kirkali.   

Abstract

BACKGROUND: The recently introduced 2004 World Health Organisation (WHO) classification of the adult renal epithelial neoplasms is meant to replace the previous 1998 WHO classification. METHODS AND
RESULTS: The 2004 WHO classification is based on pathology and genetic abnormalities. The description of categories has been expanded to improve their recognition and new diagnostic categories are included. Emphasis has been placed on defining familial renal cancer, carcinoma associated with Xp11 translocations, carcinoma associated with neuroblastoma, multilocular cystic renal cell carcinoma, tubular, mucinous and spindle cells carcinoma; and mixed epithelial and stromal tumour. The potentially aggressive epithelioid angiomyolipoma is recognised.
CONCLUSIONS: Recognising these categories may have important implications in patients' clinical management.

Entities:  

Mesh:

Year:  2006        PMID: 16442207     DOI: 10.1016/j.eururo.2005.11.035

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  261 in total

1.  Multi-colour FISH on preoperative renal tumour biopsies to confirm the diagnosis of uncertain renal masses.

Authors:  Aliaksei Chyhrai; Jimsgene Sanjmyatav; Mieczyslaw Gajda; Olaf Reichelt; Heiko Wunderlich; Thomas Steiner; Enis Tanović; Kerstin Junker
Journal:  World J Urol       Date:  2010-06       Impact factor: 4.226

2.  FoxOs enforce a progression checkpoint to constrain mTORC1-activated renal tumorigenesis.

Authors:  Boyi Gan; Carol Lim; Gerald Chu; Sujun Hua; Zhihu Ding; Michael Collins; Jian Hu; Shan Jiang; Eliot Fletcher-Sananikone; Li Zhuang; Michelle Chang; Hongwu Zheng; Y Alan Wang; David J Kwiatkowski; William G Kaelin; Sabina Signoretti; Ronald A DePinho
Journal:  Cancer Cell       Date:  2010-11-16       Impact factor: 31.743

3.  Imaging hallmark of Xp11.2 translocation renal cell carcinoma.

Authors:  Binit Sureka; Kalpana Bansal; Ankur Arora
Journal:  Can Urol Assoc J       Date:  2015-08-10       Impact factor: 1.862

4.  Diffusion-weighted imaging versus contrast-enhanced MR imaging for the differentiation of renal oncocytomas and chromophobe renal cell carcinomas.

Authors:  Yan Zhong; Haiyi Wang; Yanguang Shen; Aitao Guo; Jia Wang; Suhai Kang; Lu Ma; Jingjing Pan; Huiyi Ye
Journal:  Eur Radiol       Date:  2017-06-19       Impact factor: 5.315

5.  Evaluation of the role of downregulation of SNF5/INI1 core subunit of SWI/SNF complex in clear cell renal cell carcinoma development.

Authors:  Elzbieta Sarnowska; Michal Szymanski; Nataliia Rusetska; Marcin Ligaj; Iga Jancewicz; Pawel Cwiek; Marta Skrodzka; Marcin Leszczynski; Joanna Szarkowska; Alicja Chrzan; Malgorzata Stachowiak; Jaroslaw Steciuk; Anna Maassen; Lech Galek; Tomasz Demkow; Janusz A Siedlecki; Tomasz J Sarnowski
Journal:  Am J Cancer Res       Date:  2017-11-01       Impact factor: 6.166

6.  Diagnostic Performance and Interreader Agreement of a Standardized MR Imaging Approach in the Prediction of Small Renal Mass Histology.

Authors:  Fernando U Kay; Noah E Canvasser; Yin Xi; Daniella F Pinho; Daniel N Costa; Alberto Diaz de Leon; Gaurav Khatri; John R Leyendecker; Takeshi Yokoo; Aaron H Lay; Nicholas Kavoussi; Ersin Koseoglu; Jeffrey A Cadeddu; Ivan Pedrosa
Journal:  Radiology       Date:  2018-02-01       Impact factor: 11.105

7.  Coexistent loss of INI1 and BRG1 expression in a rhabdoid renal cell carcinoma (RCC): implications for a possible role of SWI/SNF complex in the pathogenesis of RCC.

Authors:  Qiu Rao; Qiu-Yuan Xia; Qin Shen; Shan-Shan Shi; Pin Tu; Qun-Li Shi; Xiao-Jun Zhou
Journal:  Int J Clin Exp Pathol       Date:  2014-03-15

8.  Comparison of prognosis between patients with renal cell carcinoma on hemodialysis and those with renal cell carcinoma in the general population.

Authors:  Yasunobu Hashimoto; Toshio Takagi; Tsunenori Kondo; Junpei Iizuka; Hirohito Kobayashi; Kenji Omae; Kazuhiko Yoshida; Kazunari Tanabe
Journal:  Int J Clin Oncol       Date:  2015-03-12       Impact factor: 3.402

9.  Development and validation of a microRNA-based diagnostic assay for classification of renal cell carcinomas.

Authors:  Yael Spector; Eddie Fridman; Shai Rosenwald; Sofia Zilber; Yajue Huang; Iris Barshack; Orit Zion; Heather Mitchell; Mats Sanden; Eti Meiri
Journal:  Mol Oncol       Date:  2013-03-26       Impact factor: 6.603

Review 10.  p53 and MDM2 in renal cell carcinoma: biomarkers for disease progression and future therapeutic targets?

Authors:  Aidan P Noon; Nikolina Vlatković; Radosław Polański; Maria Maguire; Howida Shawki; Keith Parsons; Mark T Boyd
Journal:  Cancer       Date:  2010-02-15       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.